BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26138629)

  • 1. A severe interaction between Tizanidine and Ciprofloxacin.
    Abd-Elsayed A; Elsharkawy H; Sakr W
    J Clin Anesth; 2015 Dec; 27(8):698. PubMed ID: 26138629
    [No Abstract]   [Full Text] [Related]  

  • 2. Tizanidine for spasticity.
    Med Lett Drugs Ther; 1997 Jul; 39(1004):62-3. PubMed ID: 9217694
    [No Abstract]   [Full Text] [Related]  

  • 3. A clinically relevant review of tizanidine hydrochloride dose relationships to pharmacokinetics, drug safety and effectiveness in healthy subjects and patients.
    Henney HR; Runyan JD
    Int J Clin Pract; 2008 Feb; 62(2):314-24. PubMed ID: 18199279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of tizanidine.
    Roberts RC; Part NJ; Pokorny R; Muir C; Leslie GC; Emre M
    Neurology; 1994 Nov; 44(11 Suppl 9):S29-31. PubMed ID: 7970008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified release tizanidine: a review.
    Hutchinson DR
    J Int Med Res; 1989; 17(6):565-73. PubMed ID: 2697626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism.
    Granfors MT; Backman JT; Neuvonen M; Neuvonen PJ
    Clin Pharmacol Ther; 2004 Dec; 76(6):598-606. PubMed ID: 15592331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
    Henney HR; Shah J
    Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coadministration of tizanidine and ciprofloxacin: a retrospective analysis of the WHO pharmacovigilance database.
    Rudolph A; Dahmke H; Kupferschmidt H; Burden A; Weiler S
    Eur J Clin Pharmacol; 2021 Jun; 77(6):895-902. PubMed ID: 33404754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluvoxamine drastically increases concentrations and effects of tizanidine: a potentially hazardous interaction.
    Granfors MT; Backman JT; Neuvonen M; Ahonen J; Neuvonen PJ
    Clin Pharmacol Ther; 2004 Apr; 75(4):331-41. PubMed ID: 15060511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interaction of tizanidine and ciprofloxacin: case report.
    Momo K; Homma M; Kohda Y; Ohkoshi N; Yoshizawa T; Tamaoka A
    Clin Pharmacol Ther; 2006 Dec; 80(6):717-9. PubMed ID: 17178273
    [No Abstract]   [Full Text] [Related]  

  • 11. [The use of sirdalud in painful muscle tonic syndromes].
    Damulin IV
    Ter Arkh; 1997; 69(10):68-72. PubMed ID: 9471796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tizanidine-induced toxic hepatitis].
    Afonso Pérez E; Pego Reigosa R; Lancho Seco A; Brañas Fernández F
    Med Clin (Barc); 1999 Apr; 112(12):478-9. PubMed ID: 10320966
    [No Abstract]   [Full Text] [Related]  

  • 13. High-dose tizanidine abuse.
    Zullino DF; Eskenasy AC; Beeson J
    Psychopharmacol Bull; 2003; 37(3):5-6. PubMed ID: 15270008
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers.
    Shah J; Wesnes KA; Kovelesky RA; Henney HR
    Clin Ther; 2006 Sep; 28(9):1308-17. PubMed ID: 17062304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tizanidine withdrawal symptoms in stress cardiomyopathy].
    Mörkl S; Bengesser SA; Schöggl H; Bayer D; Kapfhammer HP
    Fortschr Neurol Psychiatr; 2015 Mar; 83(3):170-3. PubMed ID: 25794323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-Prescription of Strong CYP1A2 Inhibitors and the Risk of Tizanidine-Associated Hypotension: A Retrospective Cohort Study.
    Chaugai S; Dickson AL; Shuey MM; Feng Q; Barker KA; Wei WQ; Luther JM; Stein CM; Chung CP
    Clin Pharmacol Ther; 2019 Mar; 105(3):703-709. PubMed ID: 30223305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurogenic orthostatic hypotension induced by tizanidine.
    Farrell MC; Biaggioni I; Shibao CA
    Clin Auton Res; 2020 Apr; 30(2):173-175. PubMed ID: 31535247
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of tizanidine-induced hepatic injury.
    de Graaf EM; Oosterveld M; Tjabbes T; Stricker BH
    J Hepatol; 1996 Nov; 25(5):772-3. PubMed ID: 8938559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically Significant Bradycardia From Tizanidine.
    Masood U; Kahlon A; Mousa O
    Am J Ther; 2018; 25(3):e385-e386. PubMed ID: 28177941
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics of orally administered tizanidine in healthy volunteers.
    Tse FL; Jaffe JM; Bhuta S
    Fundam Clin Pharmacol; 1987; 1(6):479-88. PubMed ID: 3447935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.